FDA Approves Spark's Gene Therapy for Rare Blindness Pioneered at CHOP

Katherine A. High, Joan O’Brien, Jean Bennett and Albert Maguire of the Perelman School of Medicine are highlighted for their work on the first gene therapy to restore sight to people suffering from a rare inherited form of blindness.

・ From Philadelphia Inquirer